A Long-term Evaluation of a Novel Intravaginal Device

Completed · Not applicable

Conditions studied: Pelvic Floor Disorders, Sexual Dysfunction, Stress Incontinence

In brief

An open-label long-term evaluation of a novel intravaginal device in female patients experiencing sexual and bladder function issues.

Key facts

Study ID

NCT03073824

Run by

Joylux, Inc.

People needed

65

Starts

2017-03-06

Expected to finish

2018-11-29

Last updated by the study team

2018-12-03

Who can join

Age: 30 and older, up to 59. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• All study participants are required to be biological females (genotype XX) to participate
• Female participants will be of adult age, over 18
• Female participants with self-reported concerns with bladder and sexual function
• Female participants who have reliable and consistent computer and internet access on a daily basis

You may not qualify if…

• Female participants shall not have an active sexually transmitted disease and/or infection
• Female participants who are actively undergoing chemotherapy or radiation
• Female participants who are currently taking any cancer-related or photosensitivity drugs
• Female participants who are pregnant, who may think they are pregnant, and/or actively trying to get pregnant during the clinical study

Where it is running

• Egrari Non Invasive Center — Bellevue, Washington, United States
• Seattle Obstetrics and Gynecology Group — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.